Valuation of Corporate Growth Opportunities A Real Options Approach Financial Sector of the American Economy Series
Auteur : Ottoo Richard E.
List of Tables; List of Figures; 1. Growth Opportunities: An Overview; Introduction;Growth Opportunities; Financing Constraints; Basic Approaches to Valuation; Conclusion; The Valuation Model; Investment Decision; Production Decision; Marketing Decision; Overall Value of Corporate Growth Opportunities; Conclusion; 3. Comparative Static Analysis; Introduction; Choice of the Level of R&D; Growth Value in the Case of a Monopoly; Growth Value in the Case of Collusion; Value of Growth Opportunities with R&D; Value of Growth Opportunities with Rival R&D; Growth Opportunities with Size of Innovation Rents; Growth Opportunities with Strike Price; The Impact of R&D on the Expected Time of Discovery; Growth Opportunities with the Expected Time of Innovation; Growth Opportunities with the Return on the Hedge Portfolio; Conclusion; 4. Scenario Analysis: A Case Study of a Biotechnology Company; Company Background; Market Trend; Industry Competition; Risks; Investment Analysis; 5. Financing a Growth Project: A Binomal Approach; Introduction;Operating Flexibility; Financing Flexibility; The Project; The Binomial Framework; Conclusion 6. Empirical Analysis Data Sources and Empirical Design; Empirical Results; The Fama-French Methodology; Conclusion; Summary, Problems and Future Research ; Summary; Determining Parameter Values; Data and Sample Selection Problems; Future Research; Concluding Remarks; Appendix I; Appendix II; Appendix III; Bibliography; Index.
Richard E. Ottoo is Assistant Professor of Finance at Pace University.
Date de parution : 06-2000
13.8x21.6 cm
Date de parution : 08-2016
13.8x21.6 cm
Thèmes de Valuation of Corporate Growth Opportunities :
Mots-clés :
Real Option Valuation Model; Free Cash Flow Problems; comparative static analysis; PTO; corporate growth opportunities; Herfindhal Hirschman Index; empirical analysis; Compound Real Options; biotechnology; Strike Price; NPV Project; Investment Opportunity Sets; Growth Opportunities; Mature Firm; Call Option; Exercise Price; Positive NPV; Risk Free Rate; Positive NPV Project; Operating Cash Flows; Cournot Nash Equilibrium; Negative Relationship; Risk Neutral Probability; Qualitative Comparative Analysis; Obesity Drug; Cycle Time; Full Regression; Internal Cash Flows; Binomial Tree Method